SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics (CVKD) is trending due to recent pipeline expansion with VLX-1005 for heparin-induced thrombocytopenia and ongoing progress for its lead candidate tecarfarin, including manufacturing readiness and a collaboration with Abbott for its Phase 3 trial. The community is sharply divided, with bulls highlighting the potential for a "warfarin replacement" and analyst price targets, while skeptics point to cash burn concerns, dilution risk, and accusations of bot-driven pumping.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is trending after the U.S. government announced a significant investment, including a substantial equity stake and a loan, to bolster the domestic rare earth supply chain. The news has ignited strong bullish sentiment within the community, with widespread discussion around potential valuation impacts and the possibility of a short squeeze. This development also highlights the broader sector's strategic importance amid a global push for critical mineral independence and robust "mine-to-magnet" capabilities.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica (CLS) is generating significant discussion following recent volatility, spurred by reports suggesting a potential shift in Google's TPU server assembly to other suppliers, along with general market de-risking. While some express concern over valuation and recent price action, many in the community view the dip as an opportunistic entry point, anticipating strong upcoming earnings from this crucial AI infrastructure provider. The ongoing debate centers on whether the recent pullback is justified or simply market manipulation ahead of expected positive results.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne (S) is trending following its recent earnings report, which, despite strong revenue growth and improved profitability, led to a notable stock drop, with conservative guidance being a key point of community discussion. Investors are actively debating whether the stock is severely undervalued in the growing cybersecurity sector, frequently pointing to its robust balance sheet and expressing hopes for a potential acquisition. Much of the conversation reflects a strong belief in the company's long-term potential contrasting with its current low valuation, fueling speculation about market manipulation.

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quant (QNT) is trending as the community highlights its foundational role in the UK's Tokenized Deposit Pilot and the launch of Quant Fusion, positioning it as a key interoperability layer for global financial institutions integrating with blockchain. Discussions emphasize its low token supply and growing enterprise adoption, leading many to accumulate despite a period of consolidation.

Zoracles

Zoracles ($ZORA) is buzzing with community anticipation for a significant reversal and "pump," as many actively accumulate the crypto asset. Investors are keenly watching for potential upside driven by its role in the creator economy and broader market catalysts, such as the impending Clarity Act, expected to enhance adoption and liquidity across the crypto space. This underlying optimism fuels discussions about ZORA's potential for substantial price movement independent of Bitcoin's immediate direction.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is actively trending as its price hovers around key support, with the community dissecting the impact of a reported 2.05 million LTC being moved off exchanges and subsequently sold, which many attribute to recent price action. Bulls are accumulating, viewing current levels as a significant undervaluation and a prime entry point ahead of potential regulatory clarity, while bears aggressively short, citing long-term underperformance against other digital assets. This divergence in sentiment fuels intense debate over perceived market manipulation and the asset's future trajectory.

Smith & Wesson Brands, Inc. is a holding company, which engages in the manufacture, design, and provision of firearms. Its portfolio includes handguns, long guns, handcuffs, suppressor, and other firearm-related products. The firm's brands are Smith & Wesson, M&P, Thompson/Center Arms, and Gemtech. The company was founded by Horace Smith and Daniel Baird Wesson in 1852 and is headquartered in Maryville, TN.

Smith & Wesson Brands Inc

Smith & Wesson is trending due to reports of the Justice Department potentially easing firearm restrictions and export controls, which could boost the sector. The community is actively discussing a perceived increase in demand for firearms, driven by concerns over heightened civil unrest and political tensions, leading many to anticipate a surge in sales for self-defense. Despite this, some investors remain cautious, pointing to recent mixed earnings and management performance as key factors.

BitGo Holdings, Inc. provides cryptocurrency custody solutions. It offers self-custody wallet, qualified custody, liquidity and prime, and infrastructure-as-a-service. The company was founded by Michael Belshe in 2013 and is headquartered in Palo Alto, CA.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo's recent NYSE debut as a crypto infrastructure IPO has triggered a polarized community reaction, with many investors dismayed by its rapid post-listing decline and labeling it a "scam" or "busted IPO" akin to other volatile crypto plays. Despite the heavy selling pressure, a segment of the community remains bullish, emphasizing its profitable institutional custody business, significant assets under management, and unique market position as potential drivers for a future rebound.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is generating significant conversation ahead of a critical regulatory decision for its Hunter Syndrome gene therapy and recent positive functional data for its Duchenne Muscular Dystrophy program. The community is actively debating potential outcomes, including market volatility and the impact of a recent strategic partnership, with many investors perceiving the stock as deeply undervalued given its robust gene therapy pipeline in rare diseases and ocular conditions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Virax Biolabs Group Limited (VRAX) Upgraded to Buy: Here's Why

Virax Biolabs Group Limited (VRAX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Penny Stocks To Keep An Eye On - December 3rd

iRobot, Richtech Robotics, Bitfarms, Virax Biolabs Group, Nauticus Robotics, Incannex Healthcare, and Fusion Fuel Green are the seven Penny stocks to watch today, according to MarketBeat's stock...

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement

Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement Virax Biolabs Group Limited Announces Closing of $5 Million Private Placement PR Newswire LONDON, Dec. 4, 2025 Extends...

Promising Biotech Stocks To Consider - December 3rd

Capricor Therapeutics, Vertex Pharmaceuticals, Danaher, BioNTech, and Virax Biolabs Group are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are...

Virax Biolabs (VRAX) Stock Cools After Hours Following 75% Rally

VRAX shares fell 12.79% in after-hours trading following a $5 million private placement announcement.read more...

Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.

Virax Biolabs Group Ltd - Ordinary Shares - Class A

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

VRAX
Virax Biolabs Group Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VRAX News

VRAXVirax Biolabs Group Ltd